Ad
MDWD Stock Quote Trading Chart MediWound Ltd.
home / stock / mdwd / mdwd quote
Quote | MediWound Ltd. (NASDAQ:MDWD)
| Last: | $8.82 |
|---|---|
| Change Percent: | -4.13% |
| Open: | $9.23 |
| Close: | $9.20 |
| High: | $9.3807 |
| Low: | $8.82 |
| Volume: | 1,243 |
| Last Trade Date Time: | 09/28/2023 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
MDWD Last Five Trading Days
| Last | Open | Close | High | Low | Volume | Date |
|---|---|---|---|---|---|---|
| $8.82 | $9.23 | $9.2 | $9.3807 | $8.82 | 1,243 | 09-28-2023 |
| $9.2 | $8.954 | $9.2 | $9.31 | $8.92 | 9,198 | 09-27-2023 |
| $8.83 | $8.74 | $8.83 | $9.3 | $8.7 | 25,780 | 09-26-2023 |
| $8.581 | $9.02 | $8.581 | $9.285 | $8.581 | 45,703 | 09-25-2023 |
| $9.02 | $9.1 | $9.02 | $9.6 | $9.02 | 10,465 | 09-22-2023 |
| $9.16 | $9.54 | $9.16 | $9.61 | $8.88 | 58,791 | 09-21-2023 |
| $9.05 | $9.44 | $9.05 | $9.44 | $8.9553 | 13,115 | 09-20-2023 |
| $9.34 | $8.966 | $9.34 | $9.3799 | $8.839 | 54,263 | 09-19-2023 |
| $8.82 | $8.97 | $8.82 | $9.17 | $8.82 | 15,409 | 09-18-2023 |
| $9.1 | $9.05 | $9.1 | $9.5 | $8.95 | 40,757 | 09-15-2023 |
| $9 | $8.57 | $9 | $9.07 | $8.42 | 91,282 | 09-14-2023 |
| $8.58 | $7.9 | $8.58 | $8.99 | $7.87 | 28,863 | 09-13-2023 |
| $7.8 | $7.68 | $7.8 | $7.9 | $7.68 | 14,156 | 09-12-2023 |
| $7.67 | $7.2933 | $7.67 | $7.825 | $7.26 | 35,763 | 09-11-2023 |
| $7.18 | $7.49 | $7.18 | $7.55 | $7.1 | 86,845 | 09-08-2023 |
| $7.47 | $7.6 | $7.47 | $7.62 | $7.3 | 43,278 | 09-07-2023 |
| $7.6 | $7.945 | $7.6 | $7.973 | $7.6 | 29,321 | 09-06-2023 |
| $8 | $8.24 | $8 | $8.24 | $7.97 | 41,427 | 09-05-2023 |
| $8.18 | $8.25 | $8.18 | $8.25 | $8.12 | 11,500 | 09-04-2023 |
| $8.18 | $8.25 | $8.18 | $8.25 | $8.12 | 11,500 | 09-01-2023 |
MediWound Ltd. Company Name:
MDWD Stock Symbol:
NASDAQ Market:
Ad
-
YAVNE, Israel, Sept. 26, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company focused on next-generation enzymatic therapeutics for tissue repair, today announced that the U.S. Department of Defense (DoD), through the Medical Technology Enterprise C...
-
YAVNE, Israel, Sept. 21, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company focused on next-generation enzymatic therapeutics for tissue repair, today announced the U.S. commercial availability of NexoBrid ® (anacaulase-bcdb) for the remo...
-
YAVNE, Israel, Sept. 11, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD) (“MediWound”), a fully integrated biopharmaceutical company focused on next-generation enzymatic therapeutics for tissue repair, today announced its successful participation at the recently con...